Chronic obstructive pulmonary disease.
作者信息
Anthonisen N R
机构信息
University of Manitoba, Winnipeg, Manitoba.
出版信息
Can Respir J. 2007 Oct;14(7):432-4. doi: 10.1155/2007/986892.
Abstract
摘要
相似文献
1
Chronic obstructive pulmonary disease.
Can Respir J. 2007 Oct;14(7):432-4. doi: 10.1155/2007/986892.
2
Editorial: COPD management beyond bronchodilation: current targets and future prospects.
Curr Drug Targets. 2013 Feb;14(2):139-40. doi: 10.2174/1389450111314020001.
3
Roflumilast for chronic obstructive pulmonary disease.
Lancet. 2005 Nov 26;366(9500):1845; author reply 1846-7. doi: 10.1016/S0140-6736(05)67747-1.
4
[Development of cigarette smoke solution- and lipopolysaccharide-induced pulmonary emphysema in guinea pigs].
Nihon Yakurigaku Zasshi. 2010 Jan;135(1):25-9. doi: 10.1254/fpj.135.25.
5
The role of bronchodilators in controlling COPD symptoms.
Community Nurse. 2000 Jun;6(5):19-20.
6
Thomas a. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease.
Proc Am Thorac Soc. 2006 Aug;3(6):478-81. doi: 10.1513/pats.200603-058MS.
7
Travelling in time with COPD.
Thorax. 2010 Sep;65(9):763-5. doi: 10.1136/thx.2010.146811.
8
[Physiopathology of COPD: choosing the right therapeutic targets].
Rev Pneumol Clin. 2003 Apr;59(2 Pt 2):S6-10.
9
The COPD pipeline.
Nat Rev Drug Discov. 2014 Apr;13(4):253. doi: 10.1038/nrd4254. Epub 2014 Mar 14.
10
[Chronic obstructive pulmonary disease].
Med Monatsschr Pharm. 2007 May;30(5):168-76; quiz 177-8.
本文引用的文献
1
THE ELASTIC PROPERTIES OF THE EMPHYSEMATOUS LUNG AND THEIR CLINICAL SIGNIFICANCE.
J Clin Invest. 1934 Mar;13(2):295-321. doi: 10.1172/JCI100588.
2
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
Thorax. 2005 Dec;60(12):992-7. doi: 10.1136/thx.2005.045385. Epub 2005 Oct 14.
3
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.
Ann Intern Med. 2005 Feb 15;142(4):233-9. doi: 10.7326/0003-4819-142-4-200502150-00005.
4
Skeletal muscles in chronic airflow obstruction: why bother?
Am J Respir Crit Care Med. 2003 Oct 15;168(8):916-7. doi: 10.1164/rccm.2307007.
5
The physical properties of the lung in chronic obstructive pulmonary emphysema.
J Clin Invest. 1956 Apr;35(4):394-404. doi: 10.1172/JCI103290.
6
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.
Arch Intern Med. 2003 Mar 10;163(5):585-91. doi: 10.1001/archinte.163.5.585.
7
Smoking and lung function of Lung Health Study participants after 11 years.
Am J Respir Crit Care Med. 2002 Sep 1;166(5):675-9. doi: 10.1164/rccm.2112096.
8
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2001 Sep 1;164(5):770-7. doi: 10.1164/ajrccm.164.5.2012122.
9
Susceptibility genes for rapid decline of lung function in the lung health study.
Am J Respir Crit Care Med. 2001 Feb;163(2):469-73. doi: 10.1164/ajrccm.163.2.2006158.
10
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet. 1996 Oct 26;348(9035):1115-9. doi: 10.1016/S0140-6736(96)04201-8.
Zotero 插件